Igor Ilievski M.D.

Igor Ilievski, MD MBA, has a diverse and extensive work experience. Igor is currently the Director of Business Development at Validant since April 2023. Prior to that, they worked at Merative from an unspecified date in 2021 to December 2022 as the Director of Enterprise Solutions and Strategic Accounts, where they managed and grew top-tier pharma accounts. Before Merative, Igor worked at IQVIA for a significant portion of their career. At IQVIA, they held various roles including Sr. Account Manager - Global Client Services from an unspecified date in 2009 to 2021, and Client Account Manager/Senior Account Executive from 2004 to 2009. At IQVIA, they served as a subject matter expert and provided tailored solutions to pharmaceutical companies, managed client accounts, and coordinated service and business line activity. Prior to IQVIA, Igor worked at MERCK&Co.Inc. where they held positions such as Designated Country Manager - Macedonia and Albania from 2002 to 2004, Product Manager - Cardiovasculars in Bulgaria from 2000 to 2002, and Country Sales Representative in Skopje, Republic of North Macedonia from 1999 to 2000. At MERCK&Co.Inc., they led teams, managed public affairs and regulatory filings, assessed market potential, and conducted marketing and profit plans for various products.

Igor Ilievski MD MBA has a strong educational background that includes a degree in Medicine and an executive MBA. Igor attended Ss. Cyril and Methodius University in Skopje from 1992 to 1999, where they earned their MD in Medicine. Later on, from 2017 to 2018, they attended the Fox School of Business at Temple University to pursue an Executive MBA degree in Business Administration and Management, General.